
Sign up to save your podcasts
Or


There is a new meta-analysis from the Canadian Medical Association Journal that finds increased risks among smokers trying to quit and taking varenicline (Chantix). Among smokers with stable cardiovascular disease, the number needed to treat to cause an adverse cardiovascular event is about 30, yet the number needed to treat to achieve smoking cessation is 10.
Our guest, Dr. Sonal Singh, is the first author of this meta-analysis. As you’ll hear, he has strong feelings about his team’s findings.
Related links:
CMAJ paper (free)
CMAJ commentary (sorry, but it’s not free)
Physician’s First Watch coverage of the paper (free)
By NEJM Group4.5
5656 ratings
There is a new meta-analysis from the Canadian Medical Association Journal that finds increased risks among smokers trying to quit and taking varenicline (Chantix). Among smokers with stable cardiovascular disease, the number needed to treat to cause an adverse cardiovascular event is about 30, yet the number needed to treat to achieve smoking cessation is 10.
Our guest, Dr. Sonal Singh, is the first author of this meta-analysis. As you’ll hear, he has strong feelings about his team’s findings.
Related links:
CMAJ paper (free)
CMAJ commentary (sorry, but it’s not free)
Physician’s First Watch coverage of the paper (free)

7,683 Listeners

317 Listeners

2,061 Listeners

125 Listeners

497 Listeners

299 Listeners

883 Listeners

259 Listeners

3,348 Listeners

112,321 Listeners

92 Listeners

5 Listeners

92 Listeners

515 Listeners

2,549 Listeners

368 Listeners

15,995 Listeners

60 Listeners

31 Listeners

66 Listeners